• Patient Site
  • Peyronie's Disease
  • Plantar Fibromatosis
  • Dupuytren's Disease
• Healthcare Professionals

Helpful Tools For You and Your Patient

The tools in this section will help your patient communicate better with you about their condition and improvements as they go through treatment. All of the tools summarized below are available as a printable packet by clicking on the download button.

Transdermal Verapamil 15% Gel discount voucher - Your patient can submit this voucher with their new prescription and receive an additional $90 off the usual 10% discount offered on a 90 day supply.

Symptom checklist - This checklist of common symptoms will help your patient to provide you specific information about their condition.

Questions for the doctor - This tool is designed to help patients ask questions about their condition and includes common questions as well as an area for their unique questions.

Progress Report Card - Your patients can use this tool to track and communicate to you what changes and improvements they are seeing in their condition.

Insurance questionnaire - This tool will help guide your patients' conversation with their insurance company to determine if insurance will reimburse them for Transdermal Verapamil 15% Gel.

Copyright © 2007 PDLabs Inc. All rights reserved. Privacy Policy.

The information contained in this website is provided for educational purposes only and is not intended to replace discussions with your healthcare provider. All decisions regarding a patients' treatment must be made with a healthcare provider.

Transdermal Verapamil 15% Gel is available as a compounded medication exclusively from PDLabs. Transdermal Verapamil 15% Gel is not FDA approved. PDLabs is not an "internet pharmacy" and requires that an appropriate doctor-patient-pharmacist relationship be maintained. PDLabs will not fill prescriptions for patients that do not have a valid patient-doctor relationship.

Transdermal Verapamil 15% Gel is not for everyone. Patients with specific heart conditions known as atrioventricular (AV) block or Sino-Atrial (SA) block should not use calcium channel blockers such as verapamil. Patients taking the antiarrhythmic drug Tikosyn® (Dofetilide) should not use Transdermal Verapamil 15% Gel.

Patients taking digoxin or cyclosporine should have their drug levels monitored on a regular basis as verapamil may decrease the metabolism and clearance of these drugs. Patients taking antiarrhythmic drugs should consult with their doctor before taking Transdermal Verapamil 15% Gel to ensure it is safe to use. A PDLabs pharmacist can help with this discussion.

The most common side effect reported with Transdermal Verapamil 15% Gel, affecting 3-5% of Peyronie's disease patients, is varying degrees of skin irritation. Some patients using the medication for the first time may experience mild itching/irritation during the first few days of treatment. This is normal and usually resolves within 3-4 days. Other patients may experience more severe contact dermatitis, including itching, burning, redness, or swelling. More persistent or severe irritation can usually be treated with topical corticosteroids. Based on the individual symptoms, PDLabs will work with the patient and prescribing physician to determine the best course of treatment to resolve irritation.